Registry of patients treated for blood clots
Standardized, Guidelines Directed But Patients Oriented Clinical Practice Prospectively Registered
Mayo Clinic · NCT03504007
This study collects information from patients with blood clots to see how well they respond to treatment and to ensure they get the right care quickly.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT03504007 on ClinicalTrials.gov |
What this trial studies
This registry collects data on patients diagnosed with venous thromboembolism (VTE) at the Mayo Clinic's Thrombophilia Clinic. It employs a standardized approach to assess and treat patients with acute deep vein thrombosis and pulmonary embolism, ensuring timely anticoagulation therapy. The study monitors outcomes such as recurrence rates, bleeding events, and survival during the treatment period. Patients receive personalized care based on guidelines, with immediate access to necessary medications.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with acute VTE who begin anticoagulation treatment within 14 days of diagnosis.
Not a fit: Patients already on anticoagulation for other reasons or those enrolled in other anticoagulation trials may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could improve treatment protocols and patient outcomes for those suffering from VTE.
How similar studies have performed: Other registries focusing on anticoagulation therapy for VTE have shown success in improving patient outcomes and treatment adherence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • VTE seen at Thrombophilia Clinic and treatment with anti-coagulant is started within 14 days of VTE diagnosis date. Exclusion Criteria: * Patients already on anticoagulation for other reasons or enrolled into anticoagulation clinical trials.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Damon Houghton, MD, MS — Mayo Clinic
- Study coordinator: Damon Houghton, MD, MS
- Email: vteregistry@mayo.edu
- Phone: 507-266-6717
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Deep Vein Thrombosis, Acute Pulmonary Embolism, Deep Vein Thrombosis, Pulmonary Embolism, Apixaban, Rivaroxaban, Dabigatran, Edoxaban